ANN ARBOR, MI - A $14-million rehabilitation and widening of an Ann Arbor bridge at the entrance to the University of ...
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback